ESG
-
A driven power in biotechnology and ther...A newly participant in pre-OTC for biotechnology. New drug company on cell therapy, Ever ... -
Ever Supreme is registered for pre-OTC, ...Ever Supreme (6712) is registered for pre-OTC, recommend price is NT$50 per share. Benef...
-
Participation in the Cell Therapy Manufa...Dr. Hsiu-Ling Hsiao(CSO) had be invited to participate as a speaker and lead discussion at...
-
FDA APPROVAL FOR A CLINICAL PHASE I TRIA...FDA APPROVAL FOR A CLINICAL PHASE I TRIAL WITH ITS NEW MYOCARDIAL INFARCTION DRUG